Back to search

Article

Targeting synthetic lethality between non-homologous end joining and radiation in very high-risk SHH medulloblastoma

2024-11-12

Abstract excerpt

<h4>Summary</h4> Specific and biologically informed treatments for medulloblastoma, especially the highly lethal TP53 mutant SHH subgroup, remain elusive, where radiotherapy is the primary treatment option. Applying genome-wide CRISPR-Cas9 screening in combination with lethal doses of radiotherapy, we identified the main driver of radiation resistance in SHH medulloblastoma is loss of p53. A negative selection C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bc4aee5f-fc87-573b-a18d-2a204a250fca
DOI
10.1101/2024.11.11.622104
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting synthetic lethality between non-homologous end joining and radiation in very high-risk SHH medulloblastomaDOI 10.1101/2024.11.11.622104
Select a neighboring publication to make it the new centre.